Sign in
4

Changes in Ownership

Zymeworks Inc. Filed Acc 0000950170-25-004352

Options or other derivatives

  • Chief Scientific Officer acquired 132,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moore Paul Andrew · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +79,000 79,000 D
2025-01-10 Grant or award : show line 2 in the form Restricted Stock Unit +53,000 53,000 D
Loading xslF345X05/ownership.xml…